首页> 美国卫生研究院文献>BMJ Case Reports >Findings that shed new light on the possible pathogenesis of a disease or an adverse effect: G2019S LRRK2 mutation causing Parkinson’s disease without Lewy bodies
【2h】

Findings that shed new light on the possible pathogenesis of a disease or an adverse effect: G2019S LRRK2 mutation causing Parkinson’s disease without Lewy bodies

机译:新发现揭示了疾病的可能发病机理或不良影响:G2019S LRRK2突变导致帕金森病而无路易小体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The G2019S leucine-rich repeat kinase 2 gene (LRRK2) mutation has been identified in a significant proportion of familial and sporadic cases of Parkinson’s disease (PD). Until now, information on the neuropathological changes associated with the G2019S LRRK2 mutation has been sparse. We report a 77-year-old patient who presented with a 14 year history of PD but, unexpectedly, histopathological examination disclosed mild neuronal loss in the substantia nigra without α-synuclein, tau or ubiquitin cytoplasmic inclusions. A G2019S LRRK2 mutation was eventually detected. The present case confirms that clinical PD caused by G2019S mutations can be associated with non-specific nigral degeneration without Lewy
机译:在相当多的家族性和散发性帕金森氏病(PD)病例中,已经确定了富含G2019S的富含亮氨酸的重复激酶2基因(LRRK2)突变。到目前为止,有关G2019S LRRK2突变的神经病理学改变的信息很少。我们报告了一位77岁的患者,该患者有14年的PD病史,但出乎意料的是,组织病理学检查显示黑质中有轻度神经元丢失,无α-突触核蛋白,tau或泛素胞质包涵体。最终检测到G2019S LRRK2突变。本病例证实由G2019S突变引起的临床PD可以与无路易威氏症的非特异性黑色变性相关

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号